PCI Team Member and Penn Medicine Featured in Washington Post
Carter Caldwell, Director of the Penn Medicine Co-Investment Program, was featured in the Washington Post’s Medical Mysteries column which described his journey following life-changing brain surgery.
Penn Medicine and Candel Therapeutics partner to pursue potential solid tumor CAR-T cell therapy
The University of Pennsylvania’s Center for Cellular Immunotherapies, led by cell therapy pioneer Dr. Carl June, has entered into a cancer treatment collaboration with Candel Therapeutics.
Weissman Lab is Working on New Type of Vaccines to Protect Against All Coronaviruses
The Weissman Lab is working towards developing vaccines that not only target multiple COVID variants, but also multiple types of coronaviruses.
Penn spinout Capstan Therapeutics Launches with Goal of Incorporating mRNA into CAR-T Cell Therapy
This new approach to CAR-T therapy will involve mRNA therapy that directs cells in the body to make proteins to prevent or fight disease.
Tech of the Month: AI-Powered Optical Tool for Fluorescence-Guided Oncological Surgery
This tool provides immediate and accurate tumor identification without the frozen section staining process normally required, saving over 30 minutes and thousands of dollars per tumor per operation.
Jim Wilson Speaks on What’s Next for Cell and Gene Therapy in Philadelphia
On September 8, Jim Wilson, director of Penn Medicine's gene therapy program and director of Penn's orphan disease center. sat down with health care reporter John George for a wide-ranging discussion.
Penn Medicine to Conduct New Clinical Trial to Evaluate Safety and Efficacy of Chewing Gum Designed by School of Dental Medicine Researchers to Trap SARS-CoV-2 in Saliva
The trial will recruit participants from a pool of Penn Medicine employees whose responses to the PennOpen Pass screening system indicate that they may be infected with COVID-19.
OptiDX: An AI-Powered Optical Tool for Fluorescence-Guided Oncological Surgery
Feredun Azari, M.D., Sardar Azari, and Sunil Singhal, M.D., co-invented OptiDx, an AI-powered optical tool for fluorescence-guided oncological surgery.
Penn Spinout Interius BioTherapeutics Is Developing Tools to Perform Cell and Gene Engineering Directly in the Human Body
The hope is that this new technology could simplify the process of CAR-T cell therapy and make gene therapy widely available as a one-time injection to a much larger number of patients.
NCI Grant for New Cancer Telehealth Research Center of Excellence
The University of Pennsylvania (Penn) Telehealth Research Center in Cancer Care (Penn TRACE) will become one of four NCI Telehealth Research Centers of Excellence.